Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 17
Original Research
Italian Real-World Analysis of a Tyrosine Kinase Inhibitor Administration as First- or Second-Line of Therapy in Patients with Chronic Myeloid Leukemia
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,046 | Dovepress* | 3,808+ | 486 | 4,294 | |
| PubMed Central* | 238 | 84 | 322 | ||
| Totals | 4,046 | 570 | 4,616 | ||
| *Since 8 June 2021 | |||||
View citations on PubMed Central and Google Scholar